1. Home
  2. SPRY vs BHE Comparison

SPRY vs BHE Comparison

Compare SPRY & BHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • BHE
  • Stock Information
  • Founded
  • SPRY 2015
  • BHE 1979
  • Country
  • SPRY United States
  • BHE United States
  • Employees
  • SPRY N/A
  • BHE N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • BHE Electrical Products
  • Sector
  • SPRY Health Care
  • BHE Technology
  • Exchange
  • SPRY Nasdaq
  • BHE Nasdaq
  • Market Cap
  • SPRY 1.4B
  • BHE 1.3B
  • IPO Year
  • SPRY N/A
  • BHE 1990
  • Fundamental
  • Price
  • SPRY $15.69
  • BHE $37.12
  • Analyst Decision
  • SPRY Strong Buy
  • BHE Strong Buy
  • Analyst Count
  • SPRY 4
  • BHE 2
  • Target Price
  • SPRY $28.75
  • BHE $47.00
  • AVG Volume (30 Days)
  • SPRY 1.2M
  • BHE 208.2K
  • Earning Date
  • SPRY 08-05-2025
  • BHE 07-29-2025
  • Dividend Yield
  • SPRY N/A
  • BHE 1.83%
  • EPS Growth
  • SPRY N/A
  • BHE N/A
  • EPS
  • SPRY N/A
  • BHE 1.44
  • Revenue
  • SPRY $97,122,000.00
  • BHE $2,612,294,000.00
  • Revenue This Year
  • SPRY N/A
  • BHE $0.52
  • Revenue Next Year
  • SPRY $140.40
  • BHE $8.50
  • P/E Ratio
  • SPRY N/A
  • BHE $25.82
  • Revenue Growth
  • SPRY 971120.00
  • BHE N/A
  • 52 Week Low
  • SPRY $7.55
  • BHE $30.73
  • 52 Week High
  • SPRY $18.51
  • BHE $52.57
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 60.81
  • BHE 48.74
  • Support Level
  • SPRY $14.77
  • BHE $37.05
  • Resistance Level
  • SPRY $16.23
  • BHE $38.91
  • Average True Range (ATR)
  • SPRY 0.73
  • BHE 0.77
  • MACD
  • SPRY 0.12
  • BHE -0.04
  • Stochastic Oscillator
  • SPRY 84.68
  • BHE 37.19

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About BHE Benchmark Electronics Inc.

Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia and Europe of which key revenue is derived from the Americas.

Share on Social Networks: